alexa Claudette Klein |
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Claudette Klein

Claudette Klein Dr. Claudette Klein
Professor of Biochemistry and Molecular Biology
Saint Louis University

Dr. Claudette Klein is Professor of Biochemistry and Molecular Biology at the Saint Louis University, USA. She was a post-doctoral fellow at the University of California 1972 in Development of Zinc as a new chemotherapeutic option for the treatment of cancer. Dr Claudette Klein has over 7 peer reviewed publications and is funded by the NIH, NSF and several foundations. Dr Claudette Klein research interests include Zn as a chemotherapeutic agent for cancer.

Research Interest

Zn as a chemotherapeutic agent for cancer.


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version